Malignant Lymphoma in Patients with the Wiskott-Aldrich Syndrome

References

• Wiskott A. Familiarer, angeborener Morbus Werlhofii?. Mon-atschr f Kinderh 1937; 68: 212–216
   Google Scholar
• Aldrich R A, Steinberg A G, Campbell D C. Pedigree demonstrating a sex-linked recessive condition characterized by draining ears, eczematoid dermatitis, and bloody diarrhea. Pediatrics 1954; 13: 133–138
   PubMed Web of Science ®Google Scholar
• Blaese R M, Strober W, Brown R S, Waldmann T A. The Wiskott-Aldrich syndrome: A disorder with a possible defect in antigen processing or recognition. Lancet 1968; 1: 1056–1060
   PubMed Web of Science ®Google Scholar
• Blaese R M, Strober W, Waldmann T A. Immunodeficiency in the Wiskott-Aldrich syndrome. Immunodeficiency in Man and Animals, D Bergsma, R A Good, J Finstad. Sinauer Press, Hartford, Connecticut 1975
   Google Scholar
• Blaese R M, Strober W, Levy A L, Waldmann T A. Hyper-catabolism of IgG, IgA, IgM, and albumin in the Wiskott-Aldrich syndrome, a unique disorder of serum protein metabolism. J Clin Invest 1971; 50: 2331–2338
   PubMed Web of Science ®Google Scholar
• Poplack D G, Bonnard G D, Holiman B J, Blaese R M. Monocyte mediated antibody dependent cellular cytotoxicity: A clinical test of monocyte function. Blood 1976; 48: 809–816
   PubMed Web of Science ®Google Scholar
• Gatti R A, Good R A. Occurrence of malignancy in immunodeficiency diseases. A literature review. Cancer 1971; 28: 89–98
   PubMed Web of Science ®Google Scholar
• Waldmann T A, Strober W, Blaese R M. Immunodeficiency diseases and malignancy. Ann Intern Med 1972; 77: 605–628
   PubMed Web of Science ®Google Scholar
• Perry G S, III, Spector B D, Schuman L M, et al. The Wiskott-Aldrich syndrome in the United States and Canada (1892–1979). J Pediatr 1980; 97: 72–78
   PubMed Web of Science ®Google Scholar
• Rosenberg S A, Berard C W, Brown B W, et al. National Cancer Institute sponsored study of classifications of non-Hodgkin's Lymphoma: Summary and description of a working formulation for clinical usage. Cancer 1982; 49: 2112–2135
   PubMed Web of Science ®Google Scholar
• Hsu S M, Cossman J, Jaffe E S. A comparison of ABC, unlabeled antibody, and conjugated immunohistochemical methods with monoclonal and polyclonal antibodies-an examination of germinal center of tonsils. Am J Clin Pathol 1983; 80: 429–135
   PubMed Web of Science ®Google Scholar
• Periman P, Callihan T R, Lessin L, et al. Hodgkin's disease occurring in a patient with the Wiskott-Aldrich syndrome. Cancer 1980; 45: 372–376
   PubMed Web of Science ®Google Scholar
• Sellars W A, South M A. Wiskott-Aldrich syndrome with 18 year survival. Am J Dis Child 1975; 129: 622–627
   PubMedGoogle Scholar
• Pearson H A, Shulman N R, Oski F A, et al. Platelet survival in Wiskott-Aldrich syndrome. J Pediatr 1966; 68: 754–760
   PubMed Web of Science ®Google Scholar
• Takemoto K K, Rabson A S, Mullarkey M F, et al. Isolation of papovavirus from brain tumor and urine of a patient with Wiskott-Aldrich syndrome. J Natl Cancer Inst 1974; 53: 1205–1207
   PubMed Web of Science ®Google Scholar
• Faraci R P, Hoffstrand H J, Witebsky F G, et al. Malignant lymphoma of the jejunum in a patient with Wiskott-Aldrich syndrome. Arch Surg 1975; 110: 218–220
   PubMed Web of Science ®Google Scholar
• Hayakawa H, Iwata T, Yata J, et al. Primary immunodeficiency syndrome in Japan. I. Overview of a nationwide survey on primary immunodeficiency syndrome. J Clin Immunol 1981; 1: 31–39
   PubMed Web of Science ®Google Scholar
• Fasth A. Primary immunodeficiency disorders in Sweden: Cases among children, 1974–1979. J Clin Immunol 1982; 2: 86–92
   PubMed Web of Science ®Google Scholar
• Frizzera G, Rosai J, Dehner L P, et al. Lymphoreticular disorders in primary immunodeficiencies. New findings based on an up-to-date histologic classification of 35 cases. Cancer 1980; 46: 692–699
   PubMed Web of Science ®Google Scholar
• Jaffe E S. Pathologic and clinical spectrum of post-thymic T-cell malignancies. Cancer Invest 1984; 2: 413–126
   PubMed Web of Science ®Google Scholar
• Jaffe E S, Strauchen J A, Berard C W. Predictability of immunologic phenotype by morphologic criteria in diffuse aggressive non-Hodgkin's lymphomas. Am J Clin Pathol 1982; 77: 46–49
   PubMed Web of Science ®Google Scholar
• Brand M M, Marinkovich V A. Primary malignant reticulosis of the brain in Wiskott-Aldrich syndrome. Report of a case. Arch Dis Child 1969; 44: 536–541
   PubMed Web of Science ®Google Scholar
• Heidelberger K P, LeGolvan D P. Wiskott-Aldrich syndrome and cerebral neoplasia: Report of a case with localized reticulum cell sarcoma. Cancer 1974; 33: 280–284
   PubMed Web of Science ®Google Scholar
• Model L M. Primary reticulum cell sarcoma of the brain in Wiskott-Aldrich syndrome. Report of a case. Arch Neurol 1977; 34: 633–635
   PubMed Web of Science ®Google Scholar
• Schneck S A, Penn I. De novo brain tumors in renal-transplant recipients. Lancet 1971; 1: 983–986
   PubMed Web of Science ®Google Scholar
• Snider W D, Simpson D M, Aronyk K E, et al. Primary lymphoma of the central nervous system associated with acquired immune deficiency syndrome. N Engl J Med 1983; 308: 45
   PubMed Web of Science ®Google Scholar
• Snover D C, Frizzera G, Spector B D, et al. Wiskott-Aldrich syndrome: Histopathologic findings in lymph nodes and spleens of 15 patients. Human Pathol 1981; 12: 821–831
   PubMed Web of Science ®Google Scholar
• Ten Bensel R W, Stadlan E M, Krivit W. The development of malignancy in the course of the Aldrich syndrome. J Pediatr 1966; 68: 761–767
   PubMed Web of Science ®Google Scholar
• Good R A. Relation between immunity and malignancy. Proc Nat Acad Sci USA 1972; 69: 1026–1032
   PubMed Web of Science ®Google Scholar
• Chaganti R SK, Weigensberg M, Smithwick E M, et al. Wiskott-Aldrich syndrome: Chromosomal instability in phyto-hemagglutinin-stimulated blood lymphocytes. Am J Human Genet 1979; 31, 90(a)
   Web of Science ®Google Scholar
• Schwartz R S. Immunoregulation, oncogenic viruses and malignant lymphomas. Lancet 1972; 1: 1266–1269
   PubMed Web of Science ®Google Scholar